Full name
CEREC_LAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
32.50.Z - Production of medical devices, instruments, and products, including dental products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
62.09.Z - Activities related to programming, IT consulting, and related activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
86.23.Z - Dental practice
86.90.D - Healthcare
86.90.E - Healthcare
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,5 | 2,5 | 2,9 | 15,9 |
EBITDA | 3,5 | 5,7 | 6,2 | 10,2 |
Short time liabilities | 1,4 | 2,2 | 1 | -54,7 |
Equity capital | 0,6 | 5,9 | 8,3 | 41,4 |
Operating profit (EBIT) | 1,8 | 3,6 | 3,4 | -4,9 |
Assets | 9,1 | 12,8 | 14,9 | 16 |
Net profit (loss) | 1,3 | 1,9 | 2,4 | 28,3 |
Cash | 0,8 | 0,9 | 1,5 | 58,2 |
Net income from sale | 7,9 | 13,9 | 18,3 | 32 |
Liabilities and provisions for liabilities | 8,6 | 7 | 6,6 | -5,4 |
Working assets | 2,4 | 3,8 | 5,2 | 36,9 |
Depreciation | 1,8 | 2,1 | 2,8 | 36,3 |
% | % | % | p.p. | |
Profitability of capital | 231,2 | 32,2 | 29,3 | -2,9 |
Equity capital to total assets | 6,2 | 45,7 | 55,7 | 10 |
Gross profit margin | 18,5 | 18,3 | 16,1 | -2,2 |
EBITDA Margin | 44,7 | 40,9 | 34,1 | -6,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 67 | 59 | 20 | -39 |
Current financial liquidity indicator | 1.6847631931304932 | 1.6890344619750977 | 5.07956075668335 | 3,4 |
Net dept to EBITDA | 2.0093703269958496 | 0.6704652309417725 | 0.6525332927703857 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane